DW Healthcare Partners secures $210m for Founders Fund

• The fund’s closing brings DW Healthcare Partners’ total capital under management to $1.3 billion
• Founders Fund will will focus on lower mid-market healthcare investments, typically involving companies with $3 million to $6 million of EBITDA
• It has already made investments in TubeWriter and DermLite

DW Healthcare Partners, a Toronto and Park City, Utah-based healthcare private equity firm, has closed its DW Healthcare Partners Small Cap LP (Founders Fund).

The fund’s closing brings DW Healthcare Partners’ total capital under management to $1.3 billion.

Founders Fund will will focus on lower mid-market healthcare investments, typically involving companies with $3 million to $6 million of EBITDA. It has already made investments in TubeWriter and DermLite.

On the fundraising, Andrew Carragher, co-founder and managing partner said in a statement, “DWHP has been committed to identifying, building, and scaling small to medium sized healthcare companies for over twenty years. As we have raised larger funds, launching this dedicated smaller fund focused on small companies is a logical next step. This fund brings us back to our original roots. The founders fund has all the benefits of our firm-wide expertise, deep network of experienced operators and executives, and deal sourcing engine, which has over 66,000 healthcare companies in its database.”

M2O Private Fund Advisors was DW Healthcare Partners’ placement agent in the US while August Capital served in the same capacity for Canada. Kirkland & Ellis acted as legal counsel.